Aberrantly expressed KCNK1 was significantly associated with poor prognosis in a variety of cancers, such as BRCA [20], thyroid cancer [16], lung [32] and pancreatic adenocarcinomas [19]. This evidence concerns the gene KCNK1 and pancreatic adenocarcinoma.